251 related articles for article (PubMed ID: 19571597)
1. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
[TBL] [Abstract][Full Text] [Related]
2. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Amsterdam JD; Shults J
J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
Licht RW; Qvitzau S
Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.
Reimherr F; Amsterdam J; Dunner D; Adler L; Zhang S; Williams D; Marchant B; Michelson D; Nierenberg A; Schatzberg A; Feldman P
Psychiatry Res; 2010 Jan; 175(1-2):67-73. PubMed ID: 19969374
[TBL] [Abstract][Full Text] [Related]
5. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
Güdücü F; Caliyurt O; Vardar E; Tuğlu C; Abay E
Turk Psikiyatri Derg; 2005; 16(4):245-51. PubMed ID: 16362843
[TBL] [Abstract][Full Text] [Related]
6. Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder.
Caliyurt O; Guducu F
J Affect Disord; 2005 Sep; 88(1):75-8. PubMed ID: 15967511
[TBL] [Abstract][Full Text] [Related]
7. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant dose reduction and the risk of relapse in major depressive disorder.
Papakostas GI; Perlis RH; Seifert C; Fava M
Psychother Psychosom; 2007; 76(5):266-70. PubMed ID: 17700046
[TBL] [Abstract][Full Text] [Related]
9. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
[TBL] [Abstract][Full Text] [Related]
10. Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
Michelson D; Adler LA; Amsterdam JD; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF; Kelsey DK; Williams DW
J Clin Psychiatry; 2007 Apr; 68(4):582-7. PubMed ID: 17474814
[TBL] [Abstract][Full Text] [Related]
11. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
Gorgulu Y; Caliyurt O
Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B
Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291
[TBL] [Abstract][Full Text] [Related]
13. Partial sleep deprivation therapy combined with sertraline affects subjective sleep quality in major depressive disorder.
Caliyurt O; Guducu F
Sleep Med; 2005 Nov; 6(6):555-9. PubMed ID: 15994121
[TBL] [Abstract][Full Text] [Related]
14. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives.
Brunoni AR; Valiengo L; Baccaro A; Zanao TA; de Oliveira JF; Vieira GP; Bueno VF; Goulart AC; Boggio PS; Lotufo PA; Bensenor IM; Fregni F
Contemp Clin Trials; 2011 Jan; 32(1):90-8. PubMed ID: 20854930
[TBL] [Abstract][Full Text] [Related]
15. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
16. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
Sarris J; Kavanagh DJ; Deed G; Bone KM
Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
Levkovitz Y; Tedeschini E; Papakostas GI
J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes.
Williams MM; Clouse RE; Nix BD; Rubin EH; Sayuk GS; McGill JB; Gelenberg AJ; Ciechanowski PS; Hirsch IB; Lustman PJ
Diabetes Care; 2007 Apr; 30(4):801-6. PubMed ID: 17392541
[TBL] [Abstract][Full Text] [Related]
19. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
[TBL] [Abstract][Full Text] [Related]
20. Depression and panic disorder after heart transplantation--treatment with sertraline.
Hesslinger B; Van de Loo A; Klecha D; Härter M; Schmidt-Schweda S
Pharmacopsychiatry; 2002 Jan; 35(1):31-2. PubMed ID: 11819158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
